MedPath

TENSIVE SRL

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy

Not Applicable
Recruiting
Conditions
Mastectomy, Segmental
Breast Neoplasm Malignant Female
First Posted Date
2023-07-12
Last Posted Date
2024-11-22
Lead Sponsor
Tensive SRL
Target Recruit Count
92
Registration Number
NCT05941299
Locations
🇮🇹

IEO Istituto Europeo di Oncologia, Milan, Italy

🇮🇹

A.O.U. Pisana - Ospedale Santa Chiara, Pisa, Italy

🇪🇸

Complejo Hospitalario Universitario A Coruña, A Coruña, Spain

REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follow-up

Active, not recruiting
Conditions
Breast Diseases
First Posted Date
2022-09-08
Last Posted Date
2024-02-08
Lead Sponsor
Tensive SRL
Target Recruit Count
14
Registration Number
NCT05533099
Locations
🇮🇹

Unità Operativa di Senologia (Breast Surgery Unit), Ospedale Santa Chiara, Pisa, Italy

REGENERA Implant in Excised Non-Malignant Breast Lesions

Not Applicable
Completed
Conditions
Benign Breast Disease
First Posted Date
2019-10-18
Last Posted Date
2022-02-08
Lead Sponsor
Tensive SRL
Target Recruit Count
15
Registration Number
NCT04131972
Locations
🇮🇹

Azienda Ospedaliero Universitaria Pisana, Pisa, Italy

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.